Thermo Fisher Scientific

The multiplexed PCR kit will target mutations associated with cystic fibrosis that are highly prevalent in the US, and the firm is also eyeing the Middle East and Africa.

Genetic profiles generated by Thermo Fisher's Yfiler Plus PCR amplification kit can now be included in the FBI's DNA indexing system.

The university's new court documents allege that Life Tech, its co-plaintiff in the previous suit, "fraudulently" induced it to settle the case against Illumina.

The joint GenomeWeb/Bank of America survey showed that most respondents had one preferred supplier despite the prevalence of a multitude of online catalogs.

The company is working to secure US pharmaceutical partners for its Idylla system and expects its US activities to begin driving growth by the end of 2017

This Week in Nature

In Nature this week: multi-omic neuroscience quantitative trait locus resource, and more.

The company believes its product, called Constellation, will differentiate itself from current commercial offerings in terms of throughput and multiplexing capability.

Thermo Fisher has acquired the contract development and manufacturing organization for $35 per share in cash.

Enzo Biochem, Enzo Life Sciences, and Yale University had originally brought the suit against Life Technologies, now part of Thermo Fisher, in 2004.

The company may use the proceeds of the loans to help fund the $7.2 billion acquisition of Patheon. The loan facility follows a $1.5 billion senior notes offering by Thermo Fisher last week.

Pages

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.